Questions about the safety of vaccines
Friday, February 27, 2009
Health Officials were forced to 21,000 doses of meningitis C vaccine v00r to withdraw from GP practices across Britain showed that after a number of doses could be contaminated with a toxic blood using bacteria.
More than 60,000 doses of the vaccine that is given to all four-month-old babies, may be contaminated with hospital acquired infection, the bacterium Staphylococcus aureus, and one third of them had already been sent to vaccination clinics before officials were aware of the problem.
It is assumed that officials within the Ministry of Health and the vaccine manufacturers since Tuesday should know of the problem only last night after an emergency expenditure to have been approached by The Independent about the possible contamination.
Last night the Tory health team demanded answers about why the delay had lasted for the vaccine to withdraw and said that there may be need for an investigation. It is not known how many children the dose received but an official said that so far has had no reports of any adverse reactions.
In a statement the Ministry of Health denied that infected samples in the British market had come. "Two parties are identified and recalled as a purely preventive measure. These two parties have all passed routine quality testing including sterility test. "
The revelation comes at a critical moment given the fact that many parents are still suspicious about vaccinations in children due to the unfounded fears about the measles, mumps and rubella (MMR) vaccine that was incorrect in connection with autism in 10 years study published ago and since then has been revoked.
The meningitis C vaccine, sold under the trade name Menjugate, manufactured and packed in Italy by Novartis, a multinational pharmaceutical company. An insider told The Independent that any infection with Staphylococcus, which is associated with MRSA may have occurred during the preparation of the vaccine in production in Siena.